@prefix dct: <http://purl.org/dc/terms/> .
  @prefix geo: <http://www.w3.org/2003/01/geo/wgs84_pos#> .
  @prefix doi: <https://doi.org/> .
  @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
  @prefix skos: <http://www.w3.org/2004/02/skos/core#> .
  @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
  @prefix bibo: <http://purl.org/ontology/bibo/> .
  @prefix event: <http://purl.org/NET/c4dm/event.owl#> .
  @prefix eprel: <http://eprints.org/relation/> .
  @prefix cc: <http://creativecommons.org/ns#> .
  @prefix dc: <http://purl.org/dc/elements/1.1/> .
  @prefix foaf: <http://xmlns.com/foaf/0.1/> .
  @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
  @prefix owl: <http://www.w3.org/2002/07/owl#> .
  @prefix ep: <http://eprints.org/ontology/> .
  @prefix void: <http://rdfs.org/ns/void#> .
  @prefix epid: <https://arxiv.universalpublishings.com/id/> .

<>
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/96376>;
	rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .

<https://arxiv.universalpublishings.com/id/document/18001>
	dct:hasPart <https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf>;
	ep:hasFile <https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf>;
	rdf:type bibo:Document,
		ep:Document;
	rdfs:label "IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS (PDF)"^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/96376#authors>
	rdf:_1 <https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252>;
	rdf:_2 <https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c>;
	rdf:_3 <https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421> .

<https://arxiv.universalpublishings.com/id/eprint/96376/1/137-142.pdf>
	rdfs:label "137-142.pdf"^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/96376/>
	dc:format "text/html";
	dc:title "HTML Summary of #96376 \n\nIMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS\n\n";
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/96376> .

<https://arxiv.universalpublishings.com/id/eprint/96376>
	bibo:abstract "Immune-mediated microvascular thrombosis (IMMT) is a complex disorder driven by immune dysregulation, leading to microvascular occlusion and necessitating anticoagulant therapy. This study evaluates the impact of anticoagulant therapy on hemostatic parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6]) in 45 patients with IMMT. Patients were followed for 12 months, receiving either warfarin or direct oral anticoagulants (DOACs). D-dimer levels decreased significantly (1.5 µg/mL to 0.6 µg/mL, p&lt;0.01), with DOACs showing greater reduction (p=0.02). Fibrinogen remained elevated in 60% of patients (mean 4.3 ± 0.9 g/L), correlating with CRP (r=0.65, p&lt;0.01). IL-6 levels declined from 12.5 pg/mL to 5.8 pg/mL (p&lt;0.05), reflecting reduced inflammation. Thrombotic recurrence occurred in 18% of patients, associated with persistent fibrinogen elevation (OR 2.9, 95% CI 1.1–7.6, p=0.03). These findings highlight the role of hemostatic and inflammatory markers in monitoring therapy efficacy and predicting outcomes in IMMT, supporting personalized treatment approaches."^^xsd:string;
	bibo:authorList <https://arxiv.universalpublishings.com/id/eprint/96376#authors>;
	bibo:issue "5";
	bibo:status <http://purl.org/ontology/bibo/status/published>;
	bibo:volume "2";
	dc:hasVersion <https://arxiv.universalpublishings.com/id/document/18001>;
	dct:creator <https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252>,
		<https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421>,
		<https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c>;
	dct:date "2025-05-17";
	dct:isPartOf <https://arxiv.universalpublishings.com/id/repository>,
		<https://arxiv.universalpublishings.com/id/publication/ext-546e52ae7c506fc5aad4ed9f115c9825>;
	dct:title "IMPACT OF ANTICOAGULANT THERAPY ON HEMOSTATIC AND INFLAMMATORY MARKERS IN PATIENTS WITH IMMUNE-MEDIATED MICROVASCULAR THROMBOSIS"^^xsd:string;
	ep:hasDocument <https://arxiv.universalpublishings.com/id/document/18001>;
	ep:hasPublished <https://arxiv.universalpublishings.com/id/document/18001>;
	rdf:type bibo:AcademicArticle,
		bibo:Article,
		ep:ArticleEPrint,
		ep:EPrint;
	rdfs:seeAlso <https://arxiv.universalpublishings.com/id/eprint/96376/> .

<https://arxiv.universalpublishings.com/id/person/ext-0cd4fd7bdcff643e66716fe55be41252>
	foaf:familyName "Kurbanova"^^xsd:string;
	foaf:givenName "Z.Ch"^^xsd:string;
	foaf:name "Z.Ch Kurbanova"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/person/ext-20ad5bd474ae485296f632e2a4745421>
	foaf:familyName "Begmatova"^^xsd:string;
	foaf:givenName "U.A"^^xsd:string;
	foaf:name "U.A Begmatova"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/person/ext-e5649e71cca6f214774d012cf6f9d21c>
	foaf:familyName "Babadjanov"^^xsd:string;
	foaf:givenName "S.A"^^xsd:string;
	foaf:name "S.A Babadjanov"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/publication/ext-546e52ae7c506fc5aad4ed9f115c9825>
	foaf:name "CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD"^^xsd:string;
	rdf:type bibo:Collection .